| Primary |
| Contraception |
53.7% |
| Product Used For Unknown Indication |
9.8% |
| Drug Use For Unknown Indication |
4.9% |
| Oral Contraception |
4.9% |
| Menorrhagia |
4.1% |
| Adenomyosis |
2.4% |
| Dysmenorrhoea |
2.4% |
| Endometriosis |
2.4% |
| Abdominal Pain |
1.6% |
| Epilepsy |
1.6% |
| Headache |
1.6% |
| Hypomenorrhoea |
1.6% |
| Menstrual Cycle Management |
1.6% |
| Pharyngeal Inflammation |
1.6% |
| Prophylaxis |
1.6% |
| Cystitis |
0.8% |
| Dysfunctional Uterine Bleeding |
0.8% |
| Flu |
0.8% |
| Gastritis |
0.8% |
| Hormone Replacement Therapy |
0.8% |
|
| Pregnancy On Oral Contraceptive |
27.6% |
| Urinary Tract Infection |
9.2% |
| Ectopic Pregnancy |
6.9% |
| Pulmonary Embolism |
5.7% |
| Metrorrhagia |
4.6% |
| Rectal Haemorrhage |
4.6% |
| Vaginal Haemorrhage |
4.6% |
| Vision Blurred |
4.6% |
| Weight Increased |
4.6% |
| Breast Cancer |
3.4% |
| Menstruation Delayed |
3.4% |
| Adverse Drug Reaction |
2.3% |
| Breast Mass |
2.3% |
| External Auditory Canal Atresia |
2.3% |
| Headache |
2.3% |
| Oedema Peripheral |
2.3% |
| Phlebitis |
2.3% |
| Pregnancy On Contraceptive |
2.3% |
| Subcutaneous Abscess |
2.3% |
| Thrombophlebitis |
2.3% |
|
| Secondary |
| Contraception |
31.8% |
| Endometriosis |
6.8% |
| Menorrhagia |
6.8% |
| Abdominal Pain |
4.5% |
| Adenomyosis |
4.5% |
| Dysmenorrhoea |
4.5% |
| Headache |
4.5% |
| Hypomenorrhoea |
4.5% |
| Menstrual Cycle Management |
4.5% |
| Prophylaxis |
4.5% |
| Depression |
2.3% |
| Dysfunctional Uterine Bleeding |
2.3% |
| Genital Haemorrhage |
2.3% |
| Hyperthyroidism |
2.3% |
| Menstrual Flow Excessive |
2.3% |
| Menstruation Irregular |
2.3% |
| Mineral Supplementation |
2.3% |
| Nasopharyngitis |
2.3% |
| Nausea |
2.3% |
| Oral Contraception |
2.3% |
|
| Pregnancy On Oral Contraceptive |
8.7% |
| Urinary Tract Infection |
8.7% |
| Vaginal Haemorrhage |
8.7% |
| Eczema |
4.3% |
| Foetal Exposure During Pregnancy |
4.3% |
| Hypoglycaemia |
4.3% |
| Low Birth Weight Baby |
4.3% |
| Ophthalmic Herpes Simplex |
4.3% |
| Pain In Extremity |
4.3% |
| Papilloma Viral Infection |
4.3% |
| Post Procedural Haemorrhage |
4.3% |
| Vaginal Discharge |
4.3% |
| Vasculitis |
4.3% |
| Ventricular Arrhythmia |
4.3% |
| Vision Blurred |
4.3% |
| Vomiting |
4.3% |
| Vulvovaginal Burning Sensation |
4.3% |
| Vulvovaginal Pain |
4.3% |
| Weight Decreased |
4.3% |
| Weight Increased |
4.3% |
|
| Concomitant |
| Contraception |
35.7% |
| Depression |
14.3% |
| Pain |
14.3% |
| Rheumatoid Arthritis |
14.3% |
| Chronic Myeloid Leukaemia |
7.1% |
| Cough |
7.1% |
| Multiple Sclerosis |
7.1% |
|
| Burning Sensation |
16.7% |
| Cardiomyopathy |
16.7% |
| Thyroid Neoplasm |
16.7% |
| Tremor |
16.7% |
| Vision Blurred |
16.7% |
| Weight Decreased |
16.7% |
|
| Interacting |
| Contraception |
60.0% |
| Iron Overload |
20.0% |
| Sickle Cell Anaemia |
20.0% |
|
| Pregnancy On Oral Contraceptive |
50.0% |
| Suffocation Feeling |
50.0% |
|
